相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer
Xuefei Shi et al.
MOLECULAR CARCINOGENESIS (2015)
Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer
Ming Sun et al.
BMC CANCER (2014)
The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism
Victor Jeannot et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer
Xiang-hua Liu et al.
BMC CANCER (2013)
Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway
Alexis B. Cortot et al.
CANCER RESEARCH (2013)
Negative regulation of lncRNA GAS5 by miR-21
Z. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2013)
Gene expression changes associated with erlotinib response in glioma cell lines
Ainoha Garcia-Claver et al.
EUROPEAN JOURNAL OF CANCER (2013)
Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence
Aparna Venkatraman et al.
NATURE (2013)
Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6
Zhihong Liu et al.
PLOS ONE (2013)
The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells
M-C Chen et al.
CELL DEATH & DISEASE (2013)
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
Alessia Noto et al.
ONCOTARGET (2013)
Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population
Jennifer Wheler et al.
ONCOTARGET (2013)
Cancer statistics for Hispanics/Latinos, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Uncovering the role of genomic dark matter in human disease
Lance Martin et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
Sandeep Sheth et al.
PLOS ONE (2012)
Control of RNA processing by a large non-coding RNA over-expressed in carcinomas
Rui Lin et al.
FEBS LETTERS (2011)
Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma
Amandine Hurbin et al.
JOURNAL OF PATHOLOGY (2011)
European Respiratory Society/American Thoracic Society/International Association for the Study of Lung Cancer International Multidisciplinary Classification of Lung Adenocarcinoma State of the Art
Christian Witt
JOURNAL OF THORACIC ONCOLOGY (2011)
The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth
Lars Henning Schmidt et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Human Cancer Long Non-Coding RNA Transcriptomes
Ewan A. Gibb et al.
PLOS ONE (2011)
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
F. Cappuzzo et al.
ANNALS OF ONCOLOGY (2010)
Transcribed dark matter: meaning or myth?
Chris P. Ponting et al.
HUMAN MOLECULAR GENETICS (2010)
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
M. Mourtada-Maarabouni et al.
ONCOGENE (2009)
The Genetic Signatures of Noncoding RNAs
John S. Mattick
PLOS GENETICS (2009)
TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer
R Pérez-Soler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
G Selvaggi et al.
ANNALS OF ONCOLOGY (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
MG Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
